Latest filing published 09 Oct 2026 for CF PharmTech, Inc. - H Shares, €15k.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Since each purchase
- -27.9%Entry HK$7.16 · Close 06 Nov 2026 HK$5.16
- -77.6%Entry HK$23.00 · Close 06 Nov 2026 HK$5.16
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Bovet Li Li: trading record in brief
Bovet Li Li is a declared insider of CF PharmTech, Inc. - H Shares (chief executive), with filings sourced from HKEX. We count 3 filings; the first trade dates from 1 April 2026 and the latest from 6 October 2026.
No open-market sale appears; the market trades are 3 purchases worth €36k. No amount is published for 1 filing, which the totals therefore leave out. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant.
On 2 out of 3 purchases, another insider of the same company was buying within the same 30 days. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time.
The latest filing, published on 9 October 2026, reports an open-market purchase of €15k in CF PharmTech, Inc. - H Shares. Between a trade and the moment it shows up on HKEX, the median delay is 4 days. Until a filing is published, the market cannot know about the trade. These figures are compiled from regulatory filings published by HKEX. They describe what insiders did and are not a recommendation.
Companies and markets linked to Bovet Li Li
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 19,300 shares@ HK$6.92160.0021% mcap42.5% of flowShareXHKGHKEX:DA20261008E00544Canonical exit: 4 Jan 2027 (T+90)
- 25,100 shares@ HK$7.29160.0029% mcap100.0% of flowShareXHKGHKEX:DA20261002E00452Canonical exit: 27 Dec 2026 (T+90)
- 8,500 sharesShareXHKGHKEX:DA20260408E00587Canonical exit: 30 Jun 2026 (T+90)
3 of 3 declarations